Carlos E. Ramírez
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Wound Healing and Treatments 2
- Musculoskeletal Disorders and Rehabilitation 1
-
- Rheumatoid Arthritis Research and Therapies 2
- Co-authors
- Maurício Javier Giuliodori (1 shared paper)Farr Reza Nezhat (1 shared paper)Matthew O. Burrell (1 shared paper)Benedict B. Benigno (1 shared paper)Babak Edraki (1 shared paper)CAMRAN R. NEZHAT (1 shared paper)Nelson N.H. Teng (1 shared paper)Daniel Gerardo Fernández-Ávila (1 shared paper)
- Journals
- Seminars in Surgical Oncology (1 paper)The Lancet (1 paper)Toxicology (1 paper)International Journal of Gynecology & Obstetrics (1 paper)Rheumatology International (1 paper)
- Partner nations
- ColombiaArgentinaPuerto Rico
In The Last Decade
Carlos E. Ramírez
7 papers receiving 423 citations
Carlos E. Ramírez's Hit Papers
Peers
Comparison fields: 5 of 54
- Rheumatology 326
- Hematology 88
- Genetics 31
- Oncology 71
- Immunology 49
Countries citing papers authored by Carlos E. Ramírez
This map shows the geographic impact of Carlos E. Ramírez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos E. Ramírez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos E. Ramírez more than expected).
Fields of papers citing papers by Carlos E. Ramírez
This network shows the impact of papers produced by Carlos E. Ramírez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos E. Ramírez. The network helps show where Carlos E. Ramírez may publish in the future.
Co-authors
The 20 scholars most cited alongside Carlos E. Ramírez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial Hit paper breakdown → | 2017 | 412 |
| 2 | 1994 | 13 | |
| 3 | 1997 | 7 | |
| 4 | Fisiopatología del paciente quemado | 2010 | 3 |
| 5 | 2022 | 2 | |
| 6 | 2020 | 1 | |
| 7 | 1992 | 1 |
About Carlos E. Ramírez
Carlos E. Ramírez is a scholar working on Rehabilitation, Rheumatology, Obstetrics and Gynecology, Reproductive Medicine and Emergency Medicine, having authored 7 papers that have together received 439 indexed citations. Recurring topics across this work include Wound Healing and Treatments (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Burn Injury Management and Outcomes (2 papers), Pediatric Urology and Nephrology Studies (1 paper), Musculoskeletal Disorders and Rehabilitation (1 paper), Endometrial and Cervical Cancer Treatments (1 paper), Aluminum toxicity and tolerance in plants and animals (1 paper) and Diabetic Foot Ulcer Assessment and Management (1 paper). The work is most often cited by research in Rheumatology (326 citations), Hematology (88 citations), Genetics (31 citations), Oncology (71 citations) and Immunology (49 citations). Carlos E. Ramírez has collaborated with scholars based in Colombia, Argentina and Puerto Rico. Frequent co-authors include Maurício Javier Giuliodori, Farr Reza Nezhat, Matthew O. Burrell, Benedict B. Benigno, Babak Edraki, CAMRAN R. NEZHAT, Nelson N.H. Teng, Daniel Gerardo Fernández-Ávila, Enrique Roberto Soriano and Perry Mark Elliott. Their work appears in journals such as Seminars in Surgical Oncology, The Lancet, Toxicology, International Journal of Gynecology & Obstetrics and Rheumatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.